Cargando…

Correlation of the disease-specific Canadian Cardiovascular Society (CCS) classification and health-related quality of life (15D) in coronary artery disease patients

BACKGROUND: Generic health-related quality of life (HRQoL) and disease-specific instruments measure HRQoL from different aspects, although generic instruments often contain dimensions that reflect common symptoms. We evaluated how the change in 15D HRQoL and Canadian Cardiovascular Society (CCS) gra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotajärvi, Jarno, Tolppanen, Anna-Maija, Hartikainen, Juha, Miettinen, Heikki, Viljakainen, Marketta, Martikainen, Janne, Roine, Risto P., Lavikainen, Piia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975144/ https://www.ncbi.nlm.nih.gov/pubmed/35363816 http://dx.doi.org/10.1371/journal.pone.0266101

Ejemplares similares

Agreement between physician- and patient-reported Canadian cardiovascular society scores among patients undergoing elective coronary angiography–The CATS study
por: Lavikainen, Piia, et al.
Publicado: (2023)

Patient-reported outcomes in coronary artery disease: the relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D
por: Lappalainen, Laura, et al.
Publicado: (2021)

Incident Hip Fractures among Community Dwelling Persons with Alzheimer’s Disease in a Finnish Nationwide Register-Based Cohort
por: Tolppanen, Anna-Maija, et al.
Publicado: (2013)

Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016)

Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer’s disease research – the Medication use among persons with Alzheimer’s disease (MEDALZ-2005) study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2013)

Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease
por: Sarycheva, Tatyana, et al.
Publicado: (2020)

Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer’s Disease
por: Sarycheva, Tatyana, et al.
Publicado: (2018)

History of Medically Treated Diabetes and Risk of Alzheimer Disease in a Nationwide Case-Control Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2013)

Antiepileptic Drug Use and the Risk of Stroke Among Community‐Dwelling People With Alzheimer Disease: A Matched Cohort Study
por: Sarycheva, Tatyana, et al.
Publicado: (2018)

Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer’s Disease: A Cohort Study in Finland
por: Lavikainen, Piia, et al.
Publicado: (2020)

Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer’s disease in 2005-2011
por: Tolppanen, Anna-Maija, et al.
Publicado: (2017)

Systemic Estrogen Use and Discontinuation After Alzheimer’s Disease Diagnosis in Finland 2005–2012: A Nationwide Exposure-Matched Cohort Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2018)

Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer’s disease: a nationwide matched cohort study
por: Taipale, Heidi, et al.
Publicado: (2017)

Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer’s Disease
por: Pisa, Federica, et al.
Publicado: (2021)

Month and Season of Birth as a Risk Factor for Alzheimer’s Disease: A Nationwide Nested Case-control Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016)

Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence
por: Lavikainen, Piia, et al.
Publicado: (2016)

Effects of COVID-19 Pandemic and Lockdown on Monitoring and Treatment Balance of Finnish Coronary Heart Disease and Type 2 Diabetes Patients
por: Lavikainen, Piia, et al.
Publicado: (2022)

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population
por: Jalkanen, Kari, et al.
Publicado: (2019)

Data-Driven Identification of Long-Term Glycemia Clusters and Their Individualized Predictors in Finnish Patients with Type 2 Diabetes
por: Lavikainen, Piia, et al.
Publicado: (2023)

β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
por: Paakinaho, Anne, et al.
Publicado: (2023)

CCS
por: Stickland, D P
Publicado: (2004)

The effect of comorbidities on survival in persons with Alzheimer’s disease: a matched cohort study
por: Rajamaki, Blair, et al.
Publicado: (2021)

Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
por: Järvinen, Heli, et al.
Publicado: (2023)

Marked Improvement in A1C Levels After Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Maintained Over 4 Years in Patients With Type 1 Diabetes
por: Mustonen, Jyrki, et al.
Publicado: (2022)

The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
por: Mustonen, Jyrki, et al.
Publicado: (2023)

Recent hospitalization and risk of antidepressant initiation in people with Parkinson’s disease
por: Hämäläinen, Iida, et al.
Publicado: (2022)

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2020)

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
por: Jalkanen, Kari, et al.
Publicado: (2021)

Type 2 Diabetes-Related Health Economic Impact Associated with Increased Whole Grains Consumption among Adults in Finland
por: Martikainen, Janne, et al.
Publicado: (2021)

Statin discontinuation in persons with and without Alzheimer’s disease
por: Vu, Mai, et al.
Publicado: (2022)

Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer’s disease: a matched cohort study
por: Rajamaki, Blair, et al.
Publicado: (2020)

Causes of death in a nationwide cohort of community-dwellers with Alzheimer’s disease
por: Tolppanen, Anna-Maija, et al.
Publicado: (2020)

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2022)

Diagnostic groups of hospital stays and outpatient visits during 10 years before Alzheimer’s disease
por: Mäklin, Kiira, et al.
Publicado: (2023)

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis
por: Paakinaho, Anne, et al.
Publicado: (2022)

Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
por: Hentilä, Eerik, et al.
Publicado: (2021)

Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
por: Latvala, Laura, et al.
Publicado: (2022)

Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer’s disease – exposure-matched cohort study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016)

Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer’s Disease
por: Vu, Mai, et al.
Publicado: (2021)

Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study
por: Koponen, Marjaana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_61aqqbt7d878qrqcit13igi1h7